NKCFO LLC’s BioNTech BNTX Stock Holding History

NKCFO LLC’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,300	Closed	-$162K	–	89
2023 Q1	$162K	Hold	1,300	–	–	0.08%	58
2022 Q4	$195K	Hold	1,300	–	–	0.09%	49
2022 Q3	$175K	Hold	1,300	–	–	0.08%	48
2022 Q2	$194K	Hold	1,300	–	–	0.07%	54
2022 Q1	$222K	Buy	+1,300	New	+$218K	0.07%	65

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NKCFO LLC's BNTX Position: Q2 2023 in Review

NKCFO LLC sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 1,300 shares — an estimated $162K sold.

NKCFO LLC first reported a position in BNTX in Q1 2022 and held it in 5 quarters. The position peaked at $222K in Q1 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

NKCFO LLC reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
NKCFO LLC sold 1,300 BioNTech shares in Q2 2023, an estimated $162K.
NKCFO LLC first reported a position in BioNTech in Q1 2022 and held it in 5 quarters.
NKCFO LLC's BioNTech position peaked at $222K in Q1 2022.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on NKCFO LLC's 13F filing for Q2 2023, filed 2 Aug 2023.